Personalized 125I Seed Interstitial Brachytherapy for Patients Aged 80 Years and Over with Early Primary High-risk Non-melanoma Skin Cancer

CONCLUSION: PISI-BT could be an alternative treatment option in patients above 80 years old with early primary high-risk NMSC and comorbidities.PMID:38018208 | DOI:10.2174/0118744710240256231103095018

Source: Current Radiopharmaceuticals - November 29, 2023 Category: Radiology Authors: Liang Yansong Wang Juan Zhang Hongtao Liu Zezhou Su Xiaohua Zhao Huanfen Zhao Rongmei Yin Jianqi Source Type: research